Verona Pharma plc (VRP.L) (LON:VRP) Shares Cross Below 200-Day Moving Average of $55.00

Verona Pharma plc (VRP.L) (LON:VRPGet Free Report) shares crossed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 55 ($0.70) and traded as low as GBX 50 ($0.64). Verona Pharma plc (VRP.L) shares last traded at GBX 55 ($0.70), with a volume of 70,791 shares.

Verona Pharma plc (VRP.L) Price Performance

The stock has a 50 day moving average price of GBX 55 and a two-hundred day moving average price of GBX 55. The company has a debt-to-equity ratio of 6.85, a quick ratio of 2.47 and a current ratio of 2.99. The company has a market capitalization of £228.00 million and a PE ratio of -1.68.

Verona Pharma plc (VRP.L) Company Profile

(Get Free Report)

Verona Pharma plc, a clinical stage biopharmaceutical company, develops and commercializes therapeutics to treat respiratory diseases. The company's product candidate is RPL554, an inhaled dual inhibitor of the enzymes phosphodiesterase 3 and 4, which has completed Phase I and II clinical trials that acts as a bronchodilator and an anti-inflammatory agent for the treatment of chronic obstructive pulmonary disease, cystic fibrosis, chronic asthma, and allergic rhinitis.

Featured Articles

Receive News & Ratings for Verona Pharma plc (VRP.L) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verona Pharma plc (VRP.L) and related companies with MarketBeat.com's FREE daily email newsletter.